The main purpose of this legislation is to enhance access for Medicare beneficiaries to innovative medical technologies that can improve healthcare quality and outcomes. Specifically, it aims to ensure that breakthrough medical devices can receive conditional approval under the Medicare New Technology Add-On Payment (NTAP) Program. This means that these new devices can be made available to patients more quickly, without unnecessary delays.